Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PACIFIC EDGE LIMITED Director's Dealing 2022

Dec 20, 2022

65539_rns_2022-12-20_182690fe-c686-467b-8dde-72035bd3ab07.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

Ongoing Disclosure Notice

Disclosure of Directors and Senior Managers Relevant Interests

Sections 297(2) and 298(2), Financial Markets Conduct Act 2013

To NZX Limited; and
Name of listed issuer: Pacific Edge Limited
Date this disclosure made: 21-Dec-22
Date of last disclosure: 18-Feb-22

Director or senior manager giving disclosure

Full name(s): Peter Meintjes
Name of listed issuer: Pacific Edge Limited
Name of related body corporate (if applicable): N/A
Position held in listed issuer: Chief Executive Officer
Pacific Edge Limited
21-Dec-22
18-Feb-22
Peter Meinties
Pacific Edge Limited
N/A
Chief Executive Officer

Summary of acquisition or disposal of relevant interest (excluding specified derivatives)

Class of affected quoted financial products: Ordinary shares
Nature of the affected relevant interest(s): Legal and beneficial owner
For that relevant interest
Number held in class before acquisition or disposal: Current interest in 3,000,000 options to acquireordinary shares
Number held in class after acquisition or disposal: Current interest in 3,185,000 ordinary shares,made up of 185,000 ordinary shares and3,000,000 options to acquire ordinary shares

Current registered holder(s): Peter Meintjes

Registered holder(s) once transfers are registered: N/A

Summary of acquisition or disposal of specified derivatives relevant interest (if applicable)

Type of affected derivative: N/A
Class of underlying financial products: N/A

Details of affected derivative-

The notional value of the derivative (if any) or the notional amount of underlying financial N/A
products (if any):
A statement as to whether the derivative is cash settled or physically settled: N/A

Maturity date of the derivative (if any): N/A

Expiry date of the derivative(if any): N/A The price specified in the terms of the derivative (if any): N/A

Any other details needed to understand how the amount of the consideration payable under the derivative or the value of the derivative is affected by the value of the underlying financial products:

For that derivative,-

Parties to the derivative: N/A

If the director or senior manager is not a party to the derivative, the nature of the relevant interest in the derivative:

Details of transactions giving rise to acquisition or disposal

Total number of transactions to which notice relates: 1

N/A
N/A

Details of transactions requiring disclosure-

Date of transaction: 20-Dec-22
Nature of transaction: Issue of shares
Name of any other party or parties to the transaction (if known): N/A

The consideration, expressed in New Zealand dollars, paid or received for the acquisition or disposal. If the consideration was not in cash and cannot be readily by converted into a cash value, describe the consideration:

Number of financial products to which the transaction related: 185,000 ordinary shares

If the issuer has a financial products trading policy that prohibits directors or senior managers from trading during any period without written clearance (a closed period) include the following details—

Whether relevant interests were acquired or disposed of during a closed period: N/A Whether prior written clearance was provided to allow the acquisition or disposal to proceed during the closed period: Date of the prior written clearance (if any): N/A

Summary of other relevant interests after acquisition or disposal:

Class of quoted financial products: N/A
Nature of relevant interest: N/A
For that relevant interest,-
Number held in class: N/A
Current registered holder(s): N/A
For a derivative relevant interest,-
Type of derivative: N/A

Details of derivative,-

The notional value of the derivative (if any) or the notional amount of underlying financialproducts (if any): N/A
A statement as to whether the derivative is cash settled or physically settled: N/A
Maturity date of the derivative (if any): N/A
Expiry date of the derivative (if any): N/A
The price's specified terms (if any): N/A
Any other details needed to understand how the amount of the consideration payableunder the derivative or the value of the derivative is affected by the value of the underlyingfinancial products: N/A
For that derivative relevant interest,- N/A
Parties to the derivative: N/A
If the director or senior manager is not a party to the derivative, the nature of the relevantinterest in the derivative: N/A

N/A N/A

Certification

I, certify that, to the best of my knowledge and belief, the information contained in this disclosure is correct and that I am duly authorised to make this disclosure by all persons for whom it is made.

Signature of director or officer:

Date of signature:

Signature of person authorised to sign on behalf of director or officer:

Date of signature:

or

Name and title of authorised person:

N/A

-DocuSigned by:
$\n Q0 + Q1 + Q2 + Q3 + Q4 + Q5\n$

--

the subscriber's performance as an employee of
the Company paid in lieu of a cash bonus and
having a value of NZD$88,800 (being NZD$0.48
per share)

Non-cash consideration being in recognition of

Ongoing Disclosure Notice

Disclosure of Directors and Senior Managers Relevant Interests

Sections 297(2) and 298(2), Financial Markets Conduct Act 2013

To NZX Limited; and
Name of listed issuer: Pacific Edge Limited
Date this disclosure made: 21-Dec-22
Date of last disclosure: 21-Oct-21

Director or senior manager giving disclosure

Full name(s): Grant Edward Gibson
Name of listed issuer: Pacific Edge Limited
Name of related body corporate (if applicable): N/A
Position held in listed issuer: Chief Financial Officer
Pacific Edge Limited
21-Dec-22
21-Oct-21
Grant Edward Gibson
Pacific Edge Limited
N/A
Chief Financial Officer

Summary of acquisition or disposal of relevant interest (excluding specified derivatives)

Options to acquire ordinary shares
Legal and beneficial owner
Current interest in 277,456 ordinary shares, made up of 27,456 ordinaryshares and 250,000 options to acquire ordinary shares
Current interest in 459,117 ordinary shares, made up of 27,456 ordinaryshares and 431,661 options to acquire ordinary shares
Grant Edward Gibson
Grant Edward Gibson

Summary of acquisition or disposal of specified derivatives relevant interest (if applicable)

Type of affected derivative: N/A
Class of underlying financial products: N/A

Details of affected derivative-

The notional value of the derivative (if any) or the notional amount of underlying financial N/A
products (if any):
A statement as to whether the derivative is cash settled or physically settled: N/A
Maturity date of the derivative (if any): N/A
Expiry date of the derivative(if any): N/A
The price specified in the terms of the derivative (if any): N/A
Any other details needed to understand how the amount of the consideration payableunder the derivative or the value of the derivative is affected by the value of the underlyingfinancial products: N/A
For that derivative,-
Parties to the derivative: N/A
If the director or senior manager is not a party to the derivative, the nature of the relevantinterest in the derivative: N/A
Details of transactions giving rise to acquisition or disposal

Total number of transactions to which notice relates: 1

N/A N/A

N/A

Details of transactions requiring disclosure-

Date of transaction: 20-Dec-22
Nature of transaction: Issue of options to acquire ordinary shares pursuant to an option
agreement between Grant Edward Gibson and Pacific Edge Limited
(Company) dated on or about the date of this disclosure notice (Option
Agreement). Subject to the continuous employment of the option holder(other than as a result of death or disability), the options will vest in three
equal tranches, with the first tranche vesting immediately on issue and
the further two tranches vesting on each of the first two anniversaries of
the issue date, as follows:
• Immediate - 60,554 options (Immediate Options)
• Year 1 - 60,554 options (Year 1 Options)• Year 2 - 60,553 options (Year 2 Options)
If the Option holder's employment ceases (other than by reason of
death or disability) vesting will occur in accordance with the terms set out
in the Option Agreement. If the Option holder dies or ceases
employment with the Company or a subsidiary of the Company due to
disability then all of the Options that have not yet vested will immediatelyvest in the Option holder as at the date of death or disability.
Options must be exercised within 4 years of the relevant vesting date,
unless the option holder ceases to be an employee of the Company (or
a subsidiary) other than as a result of death or disability in which case all
options that have vested must be exercised within two months of the
date on which the Option holder ceases to be employed.
Name of any other party or parties to the transaction (if known): N/A
The consideration, expressed in New Zealand dollars, paid or received for the acquisitionor disposal. If the consideration was not in cash and cannot be readily by converted into a Options are issued for nil consideration. To exercise any of the Options,cash consideration of:
cash value, describe the consideration: • NZD$0.48 per share for the Immediate Options;
• NZD$0.53 per share for the Year 1 Options; and
• NZD$0.58 per share for the Year 2 Options,
is payable on the exercise of the Options.
The Option holder will have the option to elect a cashless settlement in
which case the Company will issue to the Option holder a lesser number
of shares calculated as:
(i) the number of shares specified in the relevant option notice; less
(ii) an amount equal to the total exercise price for the relevant Optionsdivided by the volume weighted average price of the Company's shares
trade through the NZX Main Board over the trading day before the
Option holder's exercise of the Options (such amount represented as a
number of shares rather than a dollar value, and rounded down to the
nearest share).
Number of financial products to which the transaction related: Options to acquire 181,661 ordinary shares
If the issuer has a financial products trading policy that prohibits directors or seniormanagers from trading during any period without written clearance (a closed period)
include the following details—
Whether relevant interests were acquired or disposed of during a closed period: N/A
Whether prior written clearance was provided to allow the acquisition or disposal to N/A
proceed during the closed period:
Date of the prior written clearance (if any): N/A
Summary of other relevant interests after acquisition or disposal:
Class of quoted financial products: N/A
Nature of relevant interest: N/A
For that relevant interest,-
Number held in class: N/A
Current registered holder(s): N/A
For a derivative relevant interest,-
Type of derivative: N/A
Details of derivative,-
The notional value of the derivative (if any) or the notional amount of underlying financial N/A
products (if any):
A statement as to whether the derivative is cash settled or physically settled: N/A
Maturity date of the derivative (if any): N/A
Expiry date of the derivative (if any): N/A
The price's specified terms (if any): N/A
Any other details needed to understand how the amount of the consideration payable N/A
under the derivative or the value of the derivative is affected by the value of the underlying
financial products:For that derivative relevant interest,- N/A
Parties to the derivative: N/A
If the director or senior manager is not a party to the derivative, the nature of the relevantinterest in the derivative: N/A

Certification

I, certify that, to the best of my knowledge and belief, the information contained in thisdisclosure is correct and that I am duly authorised to make this disclosure by all persons for
whom it is made.
Signature of director or officer:
Date of signature:
or
Signature of person authorised to sign on behalf of director or officer:
Date of signature:
Name and title of authorised person: